(Q48269496)

10 February 2018

title

Interleukin-10 as a CNS therapeutic: the obstacle of the blood-brain/blood-spinal cord barrier. (English)

1 reference

10 February 2018

1

Abba J Kastin

1 reference

10 February 2018

author name string

Victoria Akerstrom

series ordinal

2

1 reference

10 February 2018

Weihong Pan

series ordinal

3

1 reference

10 February 2018

publication date

1 June 2003

1 reference

10 February 2018

published in

Molecular Brain Research

1 reference

10 February 2018

volume

114

1 reference

10 February 2018

page(s)

168-171

1 reference

10 February 2018

issue

2

1 reference

10 February 2018

Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2803%2900167-0

7 January 2021

Staphylococcal enterotoxin B and tumor-necrosis factor-alpha-induced relapses of experimental allergic encephalomyelitis: protection by transforming growth factor-beta and interleukin-10

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2803%2900167-0

7 January 2021

Central nervous system expression of IL-10 inhibits autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2803%2900167-0

7 January 2021

Systemic interleukin 10 administration inhibits brain tumor necrosis factor production in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2803%2900167-0

7 January 2021

Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2803%2900167-0

7 January 2021

Conditionally immortalized brain capillary endothelial cell lines established from a transgenic mouse harboring temperature-sensitive simian virus 40 large T-antigen gene

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2803%2900167-0

7 January 2021

Interleukin 10 protects mice from lethal endotoxemia

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2803%2900167-0

7 January 2021

Validity of multiple-time regression analysis in measurement of tritiated and iodinated leptin crossing the blood-brain barrier: meaningful controls

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2803%2900167-0

7 January 2021

Interleukin-10 improves outcome and alters proinflammatory cytokine expression after experimental traumatic brain injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2803%2900167-0

7 January 2021

Penetration of neurotrophins and cytokines across the blood-brain/blood-spinal cord barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2803%2900167-0

7 January 2021

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2803%2900167-0

7 January 2021

Effects of interleukin-10 (IL-10) on pain behavior and gene expression following excitotoxic spinal cord injury in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2803%2900167-0

7 January 2021

IL-10 reduces rat brain injury following focal stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2803%2900167-0

7 January 2021

Conditionally immortalized cell lines as a new in vitro model for the study of barrier functions.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2803%2900167-0

7 January 2021

10.1016/S0169-328X(03)00167-0

Identifiers

DOI

1 reference

10 February 2018

PubMed ID

12829328

1 reference

10 February 2018